- To serve as an important medium for the publication of original research in the field of medical science and health research, thus filling gaps in health knowledge for effective utilization of research findings
- To impart current medical knowledge and updated scientific information obtained from research to health professionals for better and appropriate health care management
- To disseminate recent basic, applied and social research findings among health personnel of different strata for enhancing worldwide health development
Archives 2018
Myanmar Health Sciences Research Journal
Volume 30, Number 3
TITLE: Hepatitis B and C Viral Infections among Hemodialysis Patients Attending 500 Bedded Yangon Specialty Hospital, Myanmar
AUTHOR: Aye Aye Lwin, Kyi May Htwe, Nan Cho Nwe Mon, Khin Than Maw, Moh Moh Hlaing, Khin Thida Thwin & Khin Saw Aye
SOURCE: Myanmar Health Sciences Research Journal, Vol. 30, No. 3, 2018
ABSTRACT: A cross-sectional study was conducted to determine the burden and risk of hepatitis B and C viral infections among hemodialysis patients attending Department of Renal Medicine, 500 bedded Yangon Specialty Hospital in 2016. One-hundred and eleven patients were tested for HBs antigen and anti-HCV antibody by one step qualitative immunochromatographic assay. Prevalences for hepatitis B and C viral infection were 7.2% and 15.3%, respectively. Two out of 111 patients had both HBV and HCV. Mean age of the study population was 48 years and 57% were male genders. Mean frequency of hemodialysis in HCV patients was significantly higher than that of HBV patients. Mean duration of hemodialysis was 21.7 months. The factors significantly related to high HCV infection were duration and frequency of hemodialysis and history of blood transfusion. The HBV positivity (7.2%) among hemodialysis patients was more or less similar to general population (6.5%) but the prevalence of HCV infection (15.3%) among hemodialysis patients was remarkably higher than that of general population (2.7%). It was highlighted that the screening and treatment strategies of these infections among high risk group are needed to reduce the morbidity and mortality due to HBV and HCV infections.
SUBJECT HEADINGS: Hemodialysis patients, Hepatitis B virus, Hepatitis C virus, Myanmar, Prevalence
FULL TEXT: